3D Hepatic Organoid-Based Advancements in LIVER Tissue Engineering

Area of Science:

• Hepatology
• Tissue Engineering
• Cell Biology

Background:

• Primary human hepatocytes (PHH) de-differentiate rapidly in 2D cultures, limiting their use in liver-associated disease research and tissue engineering.
• Three-dimensional (3D) culture systems better mimic the in vivo microenvironment, promoting hepatocyte function and longevity.
• Hepatic organoids, self-assembled microtissues, demonstrate sustained hepato-specific characteristics in vitro.

Purpose of the Study:

• To review the advantages of 3D hepatic organoid culture over conventional 2D and other 3D models.
• To discuss the applicability of hepatic organoids in liver tissue engineering.
• To highlight the role of hepatic organoids in modeling liver diseases and screening therapeutics.

Main Methods:

• Review of existing literature on primary human hepatocyte culture methods.
• Comparison of 2D, conventional 3D, and hepatic organoid culture systems.
• Analysis of hepatic organoid self-assembly and maintenance of phenotypic properties.

Main Results:

• 3D culture formats, particularly hepatic organoids, significantly improve the maintenance of PHH metabolic activity, phenotype, and longevity compared to 2D cultures.
• Hepatic organoids exhibit long-term in vitro maintenance of hepato-specific characteristics.
• Hepatic organoids are recognized as effective tools for liver disease modeling and drug screening.

Conclusions:

• 3D hepatic organoid culture represents a significant advancement over traditional methods for maintaining functional primary human hepatocytes.
• Hepatic organoids offer a promising platform for liver tissue engineering, disease modeling, and therapeutic screening.
• The self-assembly and long-term functionality of hepatic organoids make them a valuable tool in hepatology research.